Related Experiment Videos
Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up
1Department of Pediatrics, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27103.
Clinical Obstetrics and Gynecology
|June 1, 1988
Summary
Maternal serum alpha-fetoprotein (MSAFP) screening is a valuable prenatal care tool. It efficiently screens for neural tube defects and offers insights into other pregnancy complications, benefiting mothers and infants.
Area of Science:
- Prenatal Diagnostics
- Biochemical Markers in Pregnancy
- Maternal-Fetal Medicine
Background:
- Maternal serum alpha-fetoprotein (MSAFP) screening is a widely adopted component of prenatal care.
- The clinical utility of MSAFP screening has expanded beyond initial expectations.
- Understanding factors influencing MSAFP levels is crucial for accurate interpretation.
Purpose of the Study:
- To highlight the benefits and broad applicability of MSAFP screening.
- To emphasize its role in identifying neural tube defects and other pregnancy complications.
- To discuss the evolving knowledge and future refinements of MSAFP screening.
Main Methods:
- Routine offering of MSAFP screening to all pregnant patients.
- Utilizing MSAFP as an efficient and cost-effective screening method.
- Ongoing research into variables affecting MSAFP levels during pregnancy.
Main Results:
- MSAFP screening provides an efficient and cost-effective method for detecting neural tube defects.
- The test yields important information regarding various other pregnancy complications.
- The benefits of MSAFP screening have significantly surpassed initial projections.
Conclusions:
- MSAFP screening is a highly beneficial and cost-effective component of routine prenatal care.
- Continued research and refinement will enhance the application and benefits of MSAFP screening.
- This technology significantly contributes to improving maternal and infant health outcomes.